Hemoglobin level distribution of included participants. by Alejandro Rojas Chaves (20614814)

Subjects:

Proteomic and Transcriptomic Profiling Revealed Vital Molecular Events in the Transition from Goat Colostrum to Mature Milk by Xiao Zhang (152326)

Subjects:

Factor-level. by Yining Wang (432154)

“…Experimental results show that the ZM modifier significantly improves the dynamic stability and rutting resistance of the mixture, with dynamic stability increasing to 5245 and rut depth decreasing to 2.26 mm at a dosage of 0.5%. …”

BAEP, cognitive function, and ammonia levels in four groups. by Xueyan Lin (448667)

Subjects:

Top-level overview for ADHD classification study. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. by Huriye Senay Kiziltan (22298378)

Subjects:

Overview over the contents of the app program divided by level [28]. by Anton Kurapov (11346019)

Subjects:

Target miRNA information. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Heterogeneity test at different educational levels. by Yanling Li (269030)

Subjects:

Geometric mean anti-<i>Na</i>-GST-1 IgG levels over time by vaccine group, as measured by ELISA (Arbitrary Units). by David J. Diemert (8135568)

Subjects:

Key safety measures including adverse events. by Anuja Dokras (8679261)

“…Waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]; <i>p</i> = 0.01), BMI (MC −0.49 kg/m²; 95% CI [−0.88, −0.10[; <i>p</i> = 0.01), and android fat mass measured by DXA (MC −167 g; 95% CI [−264, −71[; <i>p</i> < 0.001) decreased in the COCP group over the study period whilst there was no statistically significant changes in these parameters in the metformin only group when compared to baseline.. …”

Loss of life expectancy that would result if colorectal cancer missed in 2011 had been diagnosed in 2011 (unit: years). by Hiroaki Saito (24514)

Subjects:

Estimated detected and non-detected colorectal cancer rates and their clinical stages based on colorectal cancer screening in Minamisoma City in 2011. by Hiroaki Saito (24514)

Subjects:

Conceptual diagram of survival curve and loss of life expectancy. by Hiroaki Saito (24514)

Subjects:

Loss of life expectancy by age group and stage of colorectal cancer and change if detected after one year. by Hiroaki Saito (24514)

Subjects:

Estimated distribution of colorectal cancer stage among patients assumed to have missed diagnosis in 2011 (unit: persons). by Hiroaki Saito (24514)

Subjects:

Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. by Hiroaki Saito (24514)

Subjects:

Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

Subjects:

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

Subjects:

Changes in sRAGE levels in BALF after 120 consecutive days of CS exposure. by Yue He (385239)

Subjects: